EClinicalMedicine Bennett, C L, Hoque, S, Olivieri, N, Taylor, M A, Aboulafia, D, Lubaczewski, C, Bennett, A C, Vemula, J, Schooley, B, Witherspoon, B J, Godwin, A C, Ray, P S, Yarnold, P R, Ausdenmoore, H C, Fishman, M, Herring, G, Ventrone, A, Aldaco, J, Hrushesky, W J, Restaino, J, Thomsen, H S, Marx, R, Migliorati, C, Ruggiero, S, Nabhan, C, Carson, K R, McKoy, J M, Yang, Y T, Schoen, M W, Knopf, K, Martin, L, Sartor, O, Rosen, S & Smith, W K 2021, ' Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019) : A qualitative analysis from the Southern Network on Adverse Reactions (SONAR) ', EClinicalMedicine, vol. 31, 100693 . https://doi.org/10.1016/j.eclinm.2020.100693 EClinicalMedicine, Vol 31, Iss, Pp 100693-(2021)
Yarom, N, Shapiro, C L, Peterson, D E, Van Poznak, C H, Bohlke, K, Ruggiero, S L, Migliorati, C A, Khan, A, Morrison, A, Anderson, H, Murphy, B A, Alston-Johnson, D, Mendes, R A, Beadle, B M, Jensen, S B & Saunders, D P 2019, ' Medication-related osteonecrosis of the jaw : MASCC/ISOO/ASCO clinical practice guideline ', Journal of Clinical Oncology, vol. 37, no. 25, pp. 2270-2290 . https://doi.org/10.1200/JCO.19.01186